Detalles de la búsqueda
1.
Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.
Clin Gastroenterol Hepatol
; 18(2): 511-513, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31009792
2.
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients.
Clin Gastroenterol Hepatol
; 16(6): 927-935, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29535057
3.
Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals.
Cancer Epidemiol Biomarkers Prev
; 30(12): 2188-2196, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583968
4.
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017.
Open Forum Infect Dis
; 7(2): ofaa044, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128339
5.
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
Int J STD AIDS
; 30(7): 689-695, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31046611
6.
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.
Public Health Rep
; 133(4): 452-460, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750893
7.
Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System.
Drugs
; 77(3): 313-318, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078644
Resultados
1 -
7
de 7
1
Próxima >
>>